Rebiotix
Brad Staskiewicz is an experienced engineering professional with a background in process engineering, validation, and research development. Currently serving as a Research Development Process Engineer at Rebiotix since November 2018, Brad has held various engineering roles at notable companies, including Takeda Oncology, GSK, and Novartis Consumer Health. Brad's career began with an internship at CommScope and continued with significant positions in medical and consumer health sectors. Educational credentials include a Master of Business Administration from the University of Nebraska-Lincoln, obtained in 2018, and a Bachelor of Science in Biological Systems Engineering, Pre-Medicine, from the same institution in 2010, following completion of studies at Platteview High School.
Rebiotix
Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome.